Zafgen (ZFGN) Announces Pricing of Initial Public Offering
6/19/2014 8:22:23 AM
CAMBRIDGE, Mass., June 18, 2014 (GLOBE NEWSWIRE) -- Zafgen, Inc., a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity, today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at a price to the public of $16.00 per share, before underwriting discounts. All of the common stock is being offered by Zafgen. In addition, Zafgen has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock to cover over-allotments, if any. The shares are expected to begin trading on the NASDAQ Global Market on June 19, 2014 under the symbol "ZFGN."
Help employers find you! Check out all the jobs and post your resume.
comments powered by